# Zometa Study in Pediatric Acute Lymphoblastic Leukemia

> **NCT01656512** · PHASE3 · COMPLETED · sponsor: **Children's Cancer Hospital Egypt 57357** · enrollment: 95 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** zolendronic acid
- **DRUG:** calcium & vitamin D

## Key facts

- **NCT ID:** NCT01656512
- **Lead sponsor:** Children's Cancer Hospital Egypt 57357
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-01
- **Final completion:** 2015-08
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656512, "Zometa Study in Pediatric Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01656512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*